Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good afternoon, everyone, and welcome to the Atea Pharmaceuticals Third Quarter 2024 Financial Results and Business Update Conference Call.

India needs to expand its local vaccine manufacturing and research to give better control over safety of these pharma ...

But overall, I think we’re going to see a continued push for more US-based manufacturing and job creation, similar to the previous administration’s approach. From an Indian pharma perspective, I don't ...

NTU Singapore is introducing two new undergraduate degree programmes in robotics and advanced chemical and pharmaceutical ...

Cipla’s FDA-compliant facilities and its investments in US-based units place it in a strong position to weather potential ...

These projects cover a wide range of sectors, including Chemical/Renewable Energy, Steel, Aluminium, Food Processing, ...

When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn't be ...

This article discusses continuous manufacturing and the increasing interest of this over traditional batch processing for ...

As the U.K. works to pump fresh cash into the local biopharma scene, London’s Accord Healthcare is capitalizing on the government’s renewed willingness to chip in. | Flush with a 50 million pound ...

Researchers have found a new way to use biocatalysis to improve the production of critical raw materials required for ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...